PROVIDER PROFILE · NPI 1861512030

Michael KleleM.D.

Family PracticeTotowa, NJI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

942

Unique beneficiaries

—

Total services

1,637

Distinct HCPCS

Medicare payment

$56K

Peer benchmark

Total Medicare services vs. 1,769 Family Practice providers in NJ — top quintile (cohort median 715).

PRESCRIBING · PART D · 2024

Total Rx claims

3,291

Beneficiaries

—

Total drug cost

$217K

Distinct drugs

Brand share

21.0%

Top prescribed drugs

Prednisone224 claims

Atorvastatin Calcium142 claims

Levothyroxine Sodium125 claims

Alprazolam111 claims

Azithromycin105 claims

QUALITY · MIPS · 2024

Final MIPS score

75.0

Quality

0.0

Cost

0.0

Improvement activities

0.0

Promoting interop.

0.0

Payment adjustment

0.00%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Michael Klele's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	121	313
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL INC	47	117
Jaime Ligot Family Practice · Newark, NJ	31	62
Alan Saunders Interventional Radiology · East Brunswick, NJ	12	20
Raymond Briski Family Practice · Watchung, NJ	11	30
Steven Risman Family Practice · Belleville, NJ	11	25

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history